Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Thursday, February 25, 2021, to provide a corporate update and discuss details of the Company's financial results for the quarter and year ended December 31, 2020.

To access the live conference call via phone, dial 1-(844) 835-6563. The international dial-in number is 1-(970) 315-3916. The conference ID number for the live call is 8499868.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular TherapiesIntra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact

Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Lisa Burnsjgrimaldi@burnsmc.com212-213-0006

Source: Intra-Cellular Therapies Inc.

 

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Intra Cellular Therapies Charts.
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Intra Cellular Therapies Charts.